Cargando…
Low Bone Mineral Density and Risk for Osteoporotic Fractures in Patients with Chronic Pancreatitis
Introduction: Chronic pancreatitis (CP) can lead to malnutrition, an established risk factor for low bone mineral density (BMD) and fractures. This study aims to determine the prevalence of low BMD, assess fracture incidence and explore risk factors for fractures in patients with CP. Patients and me...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308495/ https://www.ncbi.nlm.nih.gov/pubmed/34371899 http://dx.doi.org/10.3390/nu13072386 |
_version_ | 1783728294774964224 |
---|---|
author | Vujasinovic, Miroslav Nezirevic Dobrijevic, Lorena Asplund, Ebba Rutkowski, Wiktor Dugic, Ana Kahn, Mashroor Dahlman, Ingrid Sääf, Maria Hagström, Hannes Löhr, Johannes-Matthias |
author_facet | Vujasinovic, Miroslav Nezirevic Dobrijevic, Lorena Asplund, Ebba Rutkowski, Wiktor Dugic, Ana Kahn, Mashroor Dahlman, Ingrid Sääf, Maria Hagström, Hannes Löhr, Johannes-Matthias |
author_sort | Vujasinovic, Miroslav |
collection | PubMed |
description | Introduction: Chronic pancreatitis (CP) can lead to malnutrition, an established risk factor for low bone mineral density (BMD) and fractures. This study aims to determine the prevalence of low BMD, assess fracture incidence and explore risk factors for fractures in patients with CP. Patients and methods: We performed a retrospective analysis of all patients treated for CP at Karolinska University Hospital between January 1999 and December 2020. Electronic medical records were retrieved to assess demographic, laboratory and clinical data. Patients subjected to dual-energy X-ray absorptiometry (DXA) were categorised as either low BMD or normal BMD. We investigated whether the rate of fractures, defined by chart review, differed between these groups using Cox regression, adjusting the model for age, sex and body mass index (BMI). Additional within-group survival analysis was conducted to identify potential risk factors. Results: DXA was performed in 23% of patients with definite CP. Some 118 patients were included in the final analysis. Low BMD was present in 63 (53.4%) patients. Mean age at CP diagnosis in the total cohort was 53.1 years and was significantly lower in patients with normal BMD than in patients with low BMD (45.5 vs. 59.8, p < 0.001). Significant differences were observed in smoking status and disease aetiology, i.e., a higher proportion of patients with low BMD were current or former smokers, with nicotine or alcohol being a more common cause of CP (p < 0.05). Total follow-up time was 898 person-years. Fractures were found in 33 (28.0%) patients: in 5 of 55 patients (16.7%) with normal DXA and in 28 of 63 patients (44.4%) with low BMD (adjusted hazard ratio = 3.4, 95% confidence interval (CI) = 1.2–9.6). Patients with at least 3 months of consecutive pancreatic enzyme replacement therapy (PERT) or vitamin D treatment had a longer median time to fracture after CP diagnosis. Conclusion: DXA was only performed in 23% of patients with definite CP in this study, indicating a low adherence to current European guidelines. A low BMD was found in 53.4% of patients with CP, and 44% of the patients with a low BMD experienced a fracture during follow-up. Moreover, the fracture rate in patients with low BMD increased compared to those with normal BMD. |
format | Online Article Text |
id | pubmed-8308495 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83084952021-07-25 Low Bone Mineral Density and Risk for Osteoporotic Fractures in Patients with Chronic Pancreatitis Vujasinovic, Miroslav Nezirevic Dobrijevic, Lorena Asplund, Ebba Rutkowski, Wiktor Dugic, Ana Kahn, Mashroor Dahlman, Ingrid Sääf, Maria Hagström, Hannes Löhr, Johannes-Matthias Nutrients Article Introduction: Chronic pancreatitis (CP) can lead to malnutrition, an established risk factor for low bone mineral density (BMD) and fractures. This study aims to determine the prevalence of low BMD, assess fracture incidence and explore risk factors for fractures in patients with CP. Patients and methods: We performed a retrospective analysis of all patients treated for CP at Karolinska University Hospital between January 1999 and December 2020. Electronic medical records were retrieved to assess demographic, laboratory and clinical data. Patients subjected to dual-energy X-ray absorptiometry (DXA) were categorised as either low BMD or normal BMD. We investigated whether the rate of fractures, defined by chart review, differed between these groups using Cox regression, adjusting the model for age, sex and body mass index (BMI). Additional within-group survival analysis was conducted to identify potential risk factors. Results: DXA was performed in 23% of patients with definite CP. Some 118 patients were included in the final analysis. Low BMD was present in 63 (53.4%) patients. Mean age at CP diagnosis in the total cohort was 53.1 years and was significantly lower in patients with normal BMD than in patients with low BMD (45.5 vs. 59.8, p < 0.001). Significant differences were observed in smoking status and disease aetiology, i.e., a higher proportion of patients with low BMD were current or former smokers, with nicotine or alcohol being a more common cause of CP (p < 0.05). Total follow-up time was 898 person-years. Fractures were found in 33 (28.0%) patients: in 5 of 55 patients (16.7%) with normal DXA and in 28 of 63 patients (44.4%) with low BMD (adjusted hazard ratio = 3.4, 95% confidence interval (CI) = 1.2–9.6). Patients with at least 3 months of consecutive pancreatic enzyme replacement therapy (PERT) or vitamin D treatment had a longer median time to fracture after CP diagnosis. Conclusion: DXA was only performed in 23% of patients with definite CP in this study, indicating a low adherence to current European guidelines. A low BMD was found in 53.4% of patients with CP, and 44% of the patients with a low BMD experienced a fracture during follow-up. Moreover, the fracture rate in patients with low BMD increased compared to those with normal BMD. MDPI 2021-07-13 /pmc/articles/PMC8308495/ /pubmed/34371899 http://dx.doi.org/10.3390/nu13072386 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Vujasinovic, Miroslav Nezirevic Dobrijevic, Lorena Asplund, Ebba Rutkowski, Wiktor Dugic, Ana Kahn, Mashroor Dahlman, Ingrid Sääf, Maria Hagström, Hannes Löhr, Johannes-Matthias Low Bone Mineral Density and Risk for Osteoporotic Fractures in Patients with Chronic Pancreatitis |
title | Low Bone Mineral Density and Risk for Osteoporotic Fractures in Patients with Chronic Pancreatitis |
title_full | Low Bone Mineral Density and Risk for Osteoporotic Fractures in Patients with Chronic Pancreatitis |
title_fullStr | Low Bone Mineral Density and Risk for Osteoporotic Fractures in Patients with Chronic Pancreatitis |
title_full_unstemmed | Low Bone Mineral Density and Risk for Osteoporotic Fractures in Patients with Chronic Pancreatitis |
title_short | Low Bone Mineral Density and Risk for Osteoporotic Fractures in Patients with Chronic Pancreatitis |
title_sort | low bone mineral density and risk for osteoporotic fractures in patients with chronic pancreatitis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308495/ https://www.ncbi.nlm.nih.gov/pubmed/34371899 http://dx.doi.org/10.3390/nu13072386 |
work_keys_str_mv | AT vujasinovicmiroslav lowbonemineraldensityandriskforosteoporoticfracturesinpatientswithchronicpancreatitis AT nezirevicdobrijeviclorena lowbonemineraldensityandriskforosteoporoticfracturesinpatientswithchronicpancreatitis AT asplundebba lowbonemineraldensityandriskforosteoporoticfracturesinpatientswithchronicpancreatitis AT rutkowskiwiktor lowbonemineraldensityandriskforosteoporoticfracturesinpatientswithchronicpancreatitis AT dugicana lowbonemineraldensityandriskforosteoporoticfracturesinpatientswithchronicpancreatitis AT kahnmashroor lowbonemineraldensityandriskforosteoporoticfracturesinpatientswithchronicpancreatitis AT dahlmaningrid lowbonemineraldensityandriskforosteoporoticfracturesinpatientswithchronicpancreatitis AT saafmaria lowbonemineraldensityandriskforosteoporoticfracturesinpatientswithchronicpancreatitis AT hagstromhannes lowbonemineraldensityandriskforosteoporoticfracturesinpatientswithchronicpancreatitis AT lohrjohannesmatthias lowbonemineraldensityandriskforosteoporoticfracturesinpatientswithchronicpancreatitis |